230 related articles for article (PubMed ID: 22123934)
1. A rational approach to PML for the clinician.
Calabrese L
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S38-41. PubMed ID: 22123934
[TBL] [Abstract][Full Text] [Related]
2. The clinical features of PML.
Berger JR
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S8-12. PubMed ID: 22123935
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics, diagnostic criteria and treatment of progressive multifocal leukoencephalopathy].
Kuroda Y; Kosugi M
Nihon Rinsho; 2007 Aug; 65(8):1501-5. PubMed ID: 17695291
[TBL] [Abstract][Full Text] [Related]
5. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.
McGuire D; Barhite S; Hollander H; Miles M
Ann Neurol; 1995 Mar; 37(3):395-9. PubMed ID: 7695239
[TBL] [Abstract][Full Text] [Related]
6. Review of progressive multifocal leukoencephalopathy and natalizumab.
Aksamit AJ
Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C
N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229
[TBL] [Abstract][Full Text] [Related]
8. Advances in the management of PML: focus on natalizumab.
Fox R
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
10. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
Brain Nerve; 2007 Feb; 59(2):125-37. PubMed ID: 17380777
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy.
Aksamit AJ
Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
[TBL] [Abstract][Full Text] [Related]
12. [Progressive multifocal leukoencephalopathy (PML). Report of a case diagnosed by amplification of JC virus DNA from cerebrospinal fluid (CSF)].
Ito D; Yogo Y; Okita H; Tanaka K; Koto A
Rinsho Shinkeigaku; 1998 Jan; 38(1):46-50. PubMed ID: 9597910
[TBL] [Abstract][Full Text] [Related]
13. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.
Safdar A; Rubocki RJ; Horvath JA; Narayan KK; Waldron RL
Clin Infect Dis; 2002 Nov; 35(10):1250-7. PubMed ID: 12410486
[TBL] [Abstract][Full Text] [Related]
14. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
[TBL] [Abstract][Full Text] [Related]
16. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
17. Immunological and clinical consequences of treating a patient with natalizumab.
Schwab N; Höhn KG; Schneider-Hohendorf T; Metz I; Stenner MP; Jilek S; Du Pasquier RA; Gold R; Meuth SG; Ransohoff RM; Brück W; Wiendl H
Mult Scler; 2012 Mar; 18(3):335-44. PubMed ID: 21908480
[TBL] [Abstract][Full Text] [Related]
18. MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.
Phan-Ba R; Lommers E; Tshibanda L; Calay P; Dubois B; Moonen G; Clifford D; Belachew S
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):224-6. PubMed ID: 22013244
[TBL] [Abstract][Full Text] [Related]
19. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
[TBL] [Abstract][Full Text] [Related]
20. A young woman with HIV and hemiparesis.
Nelatur V; Smith B; Mital D; Parekh M
Acute Med; 2013; 12(1):21-5. PubMed ID: 23539372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
